Company: APCXW
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001683168-25-003561
Chunk: 14

Company: AppTech Payments Corp.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
 channel partners, which is essential to its long-term success. As of the date
of this report, the stockholders have not voted on approving additional shares for the Company’s Equity Incentive Plan. A
total of 2,702,632
shares of common stock were authorized under the Company’s Equity Incentive Plan, for which as of March 31, 2025, a total
of 508,167
are available for issuance.

     14 

On January 21, 2025, the Company extended the
expiration term of vested and outstanding stock options to the former CFO. The fair value was calculated both on the modification date
and prior to the modification. During the three months ended March 31, 2025, the Company recorded the option modification expense
for $49 thousand.

During the three months ended March 31, 2025,
the Company granted 1,848,332 options to purchase common stock. The grants included:

1)1,538,332
                                                                                                                                                                                       options were awarded to the former and current board of directors. The fair value of these options, which are non-plan with a
                                                                                                                                                                                       ten-year expiration term, total $646
                                                                                                                                                                                       thousand. These options have an exercise price ranging from $0.43
                                                                                                                                                                                       to $1.05
                                                                                                                                                                                       per share and a weighted average fair value of $0.42
                                                                                                                                                                                       per share on the issuance date.

2)On
January 21, 2025, the Company granted 110,000 options to the former CFO with an exercise price of $0.46, a ten-year expiration term,
and a fair value on the grant date of $0.47. The Company recognized $52 thousand related to this grant. The options were fully vested
upon the grant date.

3)On
February 21, 2025, the Company granted 200,000 options to the current CFO  with
an exercise price of $0.42, a ten-year expiration term, and a fair value on the grant date of $0.41. The Company recognized $85 thousand
related to this grant. The options were fully vested upon the grant date.

The following table summarizes option activity:

    Schedule of option activity 

    Number of  shares  
    Weighted  Average  exercise price  
    Weighted  Average  remaining years 
  
    Outstanding December 31, 2024 
     5,446,785